Table 1 Baseline Characteristics of Respondents and Non-respondents in PEP Participants
Total | Respondents | Non-respondents | |||
|---|---|---|---|---|---|
Characteristic | (N = 298) | (N = 257) | (N = 41) | P-value* | |
Socio-demographic | |||||
Age (year, Mean ± SD) | 62.0 ± 9.6 | 61.7 ± 9.6 | 63.6 ± 9.6 | 0.250 | |
Sex (n, %) | 0.204 | ||||
Male | 147 (49.3 %) | 123 (47.9 %) | 24 (58.5 %) | ||
Female | 151 (50.7 %) | 134 (52.1 %) | 17 (41.5 %) | ||
Smoking status (n, %) | 0.535 | ||||
Non-smoker | 223 (76.1 %) | 191 (75.5 %) | 32 (80.0 %) | ||
Ever smoking | 70 (23.9 %) | 62 (24.5 %) | 8 (20.0 %) | ||
Alcohol status (n, %) | 0.821 | ||||
non-drinker | 208 (71.0 %) | 179 (70.8 %) | 29 (72.5 %) | ||
Ever drinking | 85 (29.0 %) | 74 (29.2 %) | 11 (27.5 %) | ||
Educational level (n, %) | 0.051 | ||||
Secondary or below | 17 (5.8 %) | 12 (4.7 %) | 5 (12.5 %) | ||
Tertiary or above | 276 (94.2 %) | 241 (95.3 %) | 35 (87.5 %) | ||
Clinical | |||||
Biometric Data (Mean ± SD) | |||||
Weight (kg) | 65.3 ± 12.1 | 65.5 ± 12.4 | 63.6 ± 10.3 | 0.363 | |
BMI (kg/m2) | 25.7 ± 3.7 | 25.7 ± 3.7 | 25.1 ± 3.6 | 0.332 | |
Waist (cm) | 90.4 ± 9.7 | 90.6 ± 9.8 | 88.8 ± 9.7 | 0.297 | |
HbA1c (%) | 7.2 ± 1.2 | 7.3 ± 1.2 | 7.1 ± 0.9 | 0.495 | |
SBP (mmHg) | 135.9 ± 17.0 | 136.2 ± 17.4 | 134.1 ± 14.2 | 0.456 | |
DBP (mmHg) | 77.2 ± 11.2 | 77.2 ± 11.6 | 76.8 ± 8.9 | 0.830 | |
LDL-C (mmol/L) | 2.8 ± 0.8 | 2.9 ± 0.8 | 2.8 ± 0.8 | 0.806 | |
TC (mmol/L) | 4.7 ± 0.9 | 4.7 ± 0.9 | 4.8 ± 1.1 | 0.747 | |
HDL-C (mmol/L) | 1.3 ± 0.3 | 1.3 ± 0.3 | 1.3 ± 0.4 | 0.873 | |
TG (mmol/L) | 1.5 ± 0.9 | 1.5 ± 0.9 | 1.8 ± 1.0 | 0.091 | |
Duration of DM (year, Mean ± SD) | 7.3 ± 5.9 | 7.3 ± 6.0 | 7.3 ± 5.5 | 0.981 | |
Diabetic complication (n, %) | 11 (3.7 %) | 10 (3.9 %) | 1 (2.4 %) | 0.647 | |
Hypertension (n, %) | 238 (79.9 %) | 207 (80.5 %) | 31 (75.6 %) | 0.464 | |
Treatment Modality (n, %) | 0.884 | ||||
Diet only | 31 (10.4 %) | 27 (10.5 %) | 4 (9.8 %) | ||
Oral and/or insulin treated | 267 (89.6 %) | 230 (89.5 %) | 37 (90.2 %) | ||